Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ME2 | P23368 | 2/20 | 0.44 |
| ▸ | ME1 | P48163 | 2/20 | 0.44 |
| ▸ | ME3 | Q16798 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6478510 | 0.89 | HDAC1 (0.53) | MAOBHDAC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6489304 | 0.80 | HDAC1 (0.55) | HDAC1CYP2C19SMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL6350032 | 0.78 | ME2 (0.70) | HDAC1CYP2C9CYP2C19SMN1; SMN2ALDH1A1 | |
| SCHEMBL6478335 | 0.76 | HDAC1 (0.61) | HDAC1CYP2C9CYP2C19SMN1; SMN2ALDH1A1 | |
| SCHEMBL13981711 | 0.76 | HDAC1 (0.67) | HDAC1CYP2C9CYP2C19SMN1; SMN2ALDH1A1 | |
| SCHEMBL6488537 | 0.74 | GPR119 (0.45) | MAOB | |
| SCHEMBL8148183 | 0.74 | HDAC1 (0.53) | HDAC1CYP2C9CYP2C19SMN1; SMN2ALDH1A1 | |
| SCHEMBL6478140 | 0.74 | MEN1 (0.40) | MAOBCYP1A2CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL6349901 | 0.74 | HDAC1 (0.59) | HDAC1SMN1; SMN2ALDH1A1LMNAHTT | |
| SCHEMBL15331084 | 0.74 | HDAC1 (0.59) | HDAC1CYP2C9CYP2C19SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014942-A1 | Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation | NIPPON SHINYAKU CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| EP-1452525-A1 | AMIDE DERIVATIVES AND DRUGS | Nippon Shinyaku Co., Ltd. (JP) | 2004-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014942-A1 | Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation | TGFBR1, TGFBR2, TGFB1 | MAOB 3226/4885HDAC1 211/4885CYP1A2 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.